Quantcast

Latest Bioject Medical Technologies Inc. Stories

2014-05-12 12:30:45

TIGARD, Ore., May 12, 2014 /PRNewswire/ -- Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer of needle-free injection systems continues to expand global access to the company's technology. Bioject has signed an agreement with Caligor RX, Inc. to use its China distribution partners to sell its commercial devices in the region. "We are looking forward to working with Bioject to bring this important technology to the People's Republic of China," commented Joseph...

2014-04-22 08:34:13

TIGARD, Ore., April 22, 2014 /PRNewswire/ -- Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer of needle-free injection systems announced the appointment of Needle Free Solutions, LLC as the company's exclusive distributor for Pain Management applications in North America. The agreement calls for the sale of the Biojector®2000 gas-powered device and accessories for use in the application. "We are excited to be the exclusive distributor of the Bioject's...

2014-03-20 16:26:49

TIGARD, Ore., March 20, 2014 /PRNewswire/ -- Bioject Medical Technologies Inc. (OTC Pink: BJCT), a developer and manufacturer of needle-free injection therapy systems, today announced it is seeking to restructure its balance sheet, in order to secure necessary operating capital. After attempts to obtain necessary operating capital from third parties over a period of twelve months were unsuccessful, Bioject received an advance on March 17, 2014, of $500,000 from two of its directors,...

2014-01-22 08:29:45

Products include the Biojector® 2000, Vial Adapter and Bioject® Zetajet(TM) TIGARD, Ore., Jan. 22, 2014 /PRNewswire/ -- Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that Meditrend International, Bioject's Australian/New Zealand Distributor has received the Australian Register of Therapeutic Goods Certificate for the Biojector Needle-free injection Management System (Biojector® 2000),...

2008-07-17 09:01:20

Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free injection therapy systems, today announced that the Biojector(R) 2000 (B2000) was used in Vical Inc.'s (Vical) first Phase 1 human trial of H5N1 pandemic influenza DNA vaccines formulated with Vical's Vaxfectin(R) adjuvant. Data were presented today by Vical at the IBC Life Sciences Next Generation Vaccines conference held in Maryland. The double-blind, placebo-controlled, dose-escalation trial was...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related